Skip to contentN
NEUROONE MEDICAL TECHNOLOGIES Corp
N
NMTCNEUROONE MEDICAL TECHNOLOGIES Corp Q3 2025 · 10-Q
Revenue$1.70M$1.70M+105.4% vs Q3 2024 Net Income-$1.50M-$1.50MN/M vs Q3 2024 EPS Diluted-$0.19-$0.19N/M vs Q3 2024 Gross Profit$914,835+224.6% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
NEUROONE MEDICAL TECHNOLOGIES Corp · CIK 1500198 · Engraved from SEC EDGAR
Operating Cash Flowderived-$1,463,505N/M Free Cash Flowderived-$1,507,053N/M Margins · derivedGross margin53.9%+19.8 pt vs Q3 2024
Operating margin-111.2%+227.1 pt vs Q3 2024
Net margin-88.5%+246.7 pt vs Q3 2024
ended Jun 30, 2025 · filed Aug 14, 2025 · 45 d after period end